Cargando…
Understanding anti-leukemia responses to donor lymphocyte infusion
Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti...
Autores principales: | Bachireddy, Pavan, Wu, Catherine J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203631/ https://www.ncbi.nlm.nih.gov/pubmed/25340010 http://dx.doi.org/10.4161/onci.28187 |
Ejemplares similares
-
The emergence of WT1-specific T-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft-vs.- myeloma effect
por: Tyler, Eleanor M, et al.
Publicado: (2013) -
Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
por: Fernandez Botana, Iria, et al.
Publicado: (2023) -
Boosting leukemia-specific T cell responses in patients following stem cell transplantation
por: Burkhardt, Ute E, et al.
Publicado: (2013) -
High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia
por: Wierz, Marina, et al.
Publicado: (2018) -
Anti-leukemia activity of human gamma delta T cells
por: Siegers, Gabrielle M.
Publicado: (2012)